Observational Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Dec 7, 2018; 24(45): 5179-5188
Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5179
Table 2 Characteristics between groups at protocol study
WLE-NBI (n = 57)NBI-WLE (n = 55)P value
Sex (male, %)54.460.00.36
Age (yr)67.368.20.65
BMI (mean)28.227.00.23
Baseline polyp size0.002
10-19 mm16 (28.1)31 (56.4)
20-39 mm30 (52.6)22 (40.0)
≥ 40 mm11 (19.3)2 (3.6)
Location, right sided (%)79.078.20.92
Paris Classification0.34
0-Is26 (45.6)22 (40.0)
0-IIa22 (38.6)28 (50.9)
Other Combinations9 (15.8)5 (9.1)
NICE Classification0.90
NICE I8 (14.0)9 (16.4)
NICE II48 (84.2)46 (83.6)
NICE III1 (1.8)0 (0)
Baseline histology0.78
Hyperplastic2 (3.5)2 (3.6)
Adenoma with LGD26 (45.6)27 (49.1)
Adenoma with HGD22 (38.6)17 (30.9)
Sessile Serrated Adenoma (SSA)5 (8.8)6 (10.9)
Traditional serrated adenoma0 (0)2 (3.6)
Adenocarcinoma (pT1 stage)2 (3.5)1 (1.8)
Morphology of scar on site 10.12
Flat29 (50.9)20 (36.4)
Nodular elevated28 (49.1)35 (63.6)
Presence of clips on scar3 (5.3)8 (14.6)0.12
Residual neoplasia on histology assessment0.74
Negative38 (66.7)35 (63.6)
Positive19 (33.3)20 (36.4)
Polyps resected (mean, SD)2.4 (2.7)2.4 (2.7)0.92
Mean time baseline EPMR colonoscopy (min)55.951.90.38